Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Rev ; 70(12): 721-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23206285

ABSTRACT

The objective of this review was to analyze the components of vitamin D and their potential usefulness in preventing and treating colorectal cancer. The active form of vitamin D, 1α,25(OH(2) )D(3) , targets the wnt/ß-catenin pathway by upregulating key tumor suppressor genes such as E-cadherin, which promotes an epithelial phenotype, but this is only possible when the vitamin D receptor (VDR) is present. Colorectal cell lines have shown that VDR expression levels decrease in the later stages of colon cancer. In colorectal cancers with low VDR expression, treatments to increase VDR expression could target alterations at the genomic and epigenomic levels by modulating transcription factors such as SNAIL1 and by utilizing histone deacetyltransferase inhibitors, respectively. Finally, epidemiological studies suggest that the current US Recommended Dietary Allowance should be increased to 2,000 IU in order to raise serum 25(OH)D(3) levels above 30 ng/mL. This increase in vitamin D status can be obtained most efficiently from sun exposure or vitamin D supplementation. In summary, vitamin D and its metabolites could be utilized in strategies to treat and prevent colon cancer.


Subject(s)
Calcitriol/therapeutic use , Colonic Neoplasms/metabolism , Colonic Neoplasms/prevention & control , Receptors, Calcitriol/metabolism , Cell Line, Tumor , Colonic Neoplasms/drug therapy , Diet , Dietary Supplements , Humans , Transcription Factors/genetics , Transcription Factors/metabolism , Wnt Proteins/metabolism , beta Catenin/genetics , beta Catenin/metabolism
2.
Eur J Nutr ; 51(7): 861-70, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22042005

ABSTRACT

PURPOSE: Obesity increases the risk of diabetes. The dysregulation of estrogen metabolism has been associated with the susceptibility to obesity and diabetes. Here, we explore the role estrogen plays in sex differences in obesity and glucose metabolism, specifically adipocyte biology. METHODS: We randomized C57BL/6 J male, non-ovariectomized female, ovariectomized female, and ovariectomized female mice supplemented with 17ß estradiol to receive a calorie-restricted, low- or a high-fat diet (15 mice per group). We measured weight gained, calories consumed, percent body fat, abdominal adipose tissue, adipocyte size, lipogenic and adipogenic gene expression, and glucose tolerance. RESULTS: Male mice had a higher susceptibility to obesity than intact female mice. However, removal of the ovaries in female mice eliminated the protection to obesity and estrogen supplementation restored this protection. Male and ovariectomized female mice gained weight predominately in the form of abdominal adipose tissue possibly due to an increase in adipocyte size. Moreover, for mice consuming the high-fat diet, male and ovariectomized female mice had significantly higher levels of leptin mRNA and lower hormone-sensitive lipase mRNA relative to intact female mice and ovariectomized female mice supplemented with estrogen. Additionally, estrogen had a strong inhibitory effect on key adipogenic genes in non-ovariectomized female and ovx-female mice supplemented with estrogen. Finally, we show that male and ovariectomized female mice consuming the high-fat diet had a higher incidence of glucose intolerance. CONCLUSION: Estrogen protects female mice from obesity and impaired glucose tolerance possibly by modulating the expression of genes regulating adipogenesis, lipogenesis, and lipolysis.


Subject(s)
Adiposity/drug effects , Dietary Supplements , Estrogens/pharmacology , Glucose Intolerance/prevention & control , Obesity/prevention & control , Abdominal Fat/drug effects , Adipogenesis/drug effects , Animals , Body Composition , Caloric Restriction , Diet, Fat-Restricted , Diet, High-Fat , Estradiol/pharmacology , Female , Gene Expression Regulation , Glucose Intolerance/metabolism , Insulin/blood , Leptin/blood , Lipogenesis/drug effects , Lipolysis/drug effects , Male , Mice , Mice, Inbred C57BL , Obesity/metabolism , Ovariectomy/methods , Resistin/blood , Sex Factors , Sterol Esterase/metabolism
3.
J Exp Clin Cancer Res ; 30: 75, 2011 Aug 12.
Article in English | MEDLINE | ID: mdl-21838876

ABSTRACT

BACKGROUND: Alcohol consumption is an established risk factor for breast cancer metastasis. Yet, the mechanism by which alcohol promotes breast cancer metastases is unknown. The ability of cancer cells to invade through tissue barriers (such as basement membrane and interstitial stroma) is an essential step towards establishing cancer metastasis. In the present study, we identify and examine the roles of two genes, Nm23 and ITGA5, in alcohol-induced breast cancer cell invasion. METHODS: Human breast cancer T47D cells were treated with ethanol at various concentrations. Boyden chamber invasion assays were used to measure cellular invasive ability. The mRNA expression level of metastasis suppressor genes including Nm23 was determined by qRT-PCR. ITGA5 was identified using a qRT-PCR array of 84 genes important for cell-cell and cell-extracellular matrix interactions. Nm23 overexpression in addition to Nm23- and ITGA5 knock-down were used to determine the role of the Nm23-ITGA5 pathway on cellular invasive ability of T47D cells. Protein expression levels were verified by Western blot. RESULTS: Alcohol increased the invasive ability of human breast cancer T47D cells in a dose-dependent manner through the suppression of the Nm23 metastatic suppressor gene. In turn, Nm23 down-regulation increased expression of fibronectin receptor subunit ITGA5, which subsequently led to increased cellular invasion. Moreover, Nm23 overexpression was effective in suppressing the effects of alcohol on cell invasion. In addition, we show that the effects of alcohol on invasion were also inhibited by knock-down of ITGA5. CONCLUSIONS: Our results suggest that the Nm23-ITGA5 pathway plays a critical role in alcohol-induced breast cancer cell invasion. Thus, regulation of this pathway may potentially be used to prevent the establishment of alcohol-promoted metastases in human breast cancers.


Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Ethanol/pharmacology , Integrin alphaV/genetics , NM23 Nucleoside Diphosphate Kinases/genetics , Signal Transduction/drug effects , Biomarkers, Tumor/metabolism , Breast Neoplasms/genetics , Cell Adhesion/drug effects , Cell Movement/drug effects , Cell Proliferation/drug effects , Central Nervous System Depressants/pharmacology , Female , Gene Expression Profiling , Humans , Integrin alphaV/metabolism , NM23 Nucleoside Diphosphate Kinases/metabolism , Neoplasm Invasiveness , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Tumor Cells, Cultured
4.
Nutr J ; 8: 11, 2009 Feb 17.
Article in English | MEDLINE | ID: mdl-19220919

ABSTRACT

BACKGROUND: The prevalence of obesity has increased dramatically. A direct comparison in the predisposition to obesity between males, premenopausal females, and postmenopausal females with various caloric intakes has not been made. To determine the effects of sex and ovarian hormones on the susceptibility to obesity, we conducted laboratory studies with mice. To eliminate confounders that can alter body weight gain, such as age and food consumption; we used mice with the same age and controlled the amount of calories they consumed. METHODS: We determined sex-specific susceptibility to obesity between male, non-ovariectomized female, and ovariectomized female mice. To compare susceptibility to gaining body weight between males and females, animals from each sex were exposed to either a 30% calorie-restricted, low-fat (5% fat), or high-fat (35% fat) diet regimen. To establish the role of ovarian hormones in weight gain, the ovaries were surgically removed from additional female mice, and then were exposed to the diets described above. Percent body fat and percent lean mass in the mice were determined by dual energy x-ray absorptiometry (DEXA). RESULTS: In all three diet categories, male mice had a greater propensity of gaining body weight than female mice. However, ovariectomy eliminated the protection of female mice to gaining weight; in fact, ovariectomized female mice mimicked male mice in their susceptibility to weight gain. In summary, results show that male mice are more likely to become obese than female mice and that the protection against obesity in female mice is eliminated by ovariectomy. CONCLUSION: Understanding metabolic differences between males and females may allow the discovery of better preventive and treatment strategies for diseases associated with body weight such as cancer and cardiovascular disease.


Subject(s)
Dietary Fats/administration & dosage , Obesity/prevention & control , Absorptiometry, Photon , Animals , Disease Susceptibility/physiopathology , Energy Intake , Female , Gonadal Hormones/physiology , Male , Mice , Mice, Inbred C57BL , Obesity/metabolism , Ovariectomy , Sex Factors , Weight Gain
SELECTION OF CITATIONS
SEARCH DETAIL
...